Jo Nattawut

Ask VT AI

View News Summary

Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Dodgers' high-priced lineup struggles to produce offense, putting World Series title defense in jeopardy against the Blue Jays.
Leggett & Platt reports a one-off $659 million loss, but its adjusted results indicate a return to profitability with improving net margins.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Latest News

Jo Nattawut, MMA

Moraes vs Kingad

100% center coverage1 source

Jo Nattawut, MMA

Moraes vs Kingad

100% center coverage1 source

Moraes vs Kingad

Moraes vs Kingad

Ask VT AI

View News Summary

Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Dodgers' high-priced lineup struggles to produce offense, putting World Series title defense in jeopardy against the Blue Jays.
Leggett & Platt reports a one-off $659 million loss, but its adjusted results indicate a return to profitability with improving net margins.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Jo Nattawut